loadpatents
name:-0.03010892868042
name:-0.015040874481201
name:-0.00045204162597656
Hess-Stumpp; Holger Patent Filings

Hess-Stumpp; Holger

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hess-Stumpp; Holger.The latest application filed is for "novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors".

Company Profile
0.14.23
  • Hess-Stumpp; Holger - Berlin N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant 8,796,253 - Boyer , et al. August 5, 2
2014-08-05
Novel Anthranilamide Pyridinureas As Vascular Endothelial Growth Factor (vegf) Receptor Kinase Inhibitors
App 20110124680 - BOHLMANN; Rolf ;   et al.
2011-05-26
Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,906,533 - Bohlmann , et al. March 15, 2
2011-03-15
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,902,229 - Bohlmann , et al. March 8, 2
2011-03-08
Heteroaryl Substituted Pyrazole Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis
App 20100249085 - Boyer; Stephen ;   et al.
2010-09-30
Metasubstituted Thiazolidinones, Their Manufacture And Use As A Drug
App 20100048891 - SCHULZE; Klause ;   et al.
2010-02-25
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
Grant 7,615,565 - Huth , et al. November 10, 2
2009-11-10
Effector conjugates, methods for their preparation and their pharmaceutical use
Grant 7,605,136 - Bosslet , et al. October 20, 2
2009-10-20
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
Grant 7,572,794 - Bohlmann , et al. August 11, 2
2009-08-11
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
Grant 7,517,894 - Huth , et al. April 14, 2
2009-04-14
Thiazolidinones, their production and use as pharmaceutical agents
Grant 7,511,059 - Schulze , et al. March 31, 2
2009-03-31
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
Grant 7,378,522 - Strehlke , et al. May 27, 2
2008-05-27
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones
App 20070135489 - Huth; Andreas ;   et al.
2007-06-14
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
Grant 7,202,260 - Huth , et al. April 10, 2
2007-04-10
Thiazolidinones, their production and use as pharmaceutical agents
App 20070037862 - Siemeister; Gerhard ;   et al.
2007-02-15
Metasubstituted thiazolidinones, their manufacture and use as a drug
App 20070015759 - Schulze; Volker Klaus ;   et al.
2007-01-18
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
App 20070015794 - Huth; Andreas ;   et al.
2007-01-18
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
Grant 7,148,357 - Huth , et al. December 12, 2
2006-12-12
New effector conjugates, methods for their preparation and their pharmaceutical use
App 20060276413 - Bosslet; Klaus ;   et al.
2006-12-07
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060264425 - Bohlmann; Rolf ;   et al.
2006-11-23
Thiazolidinones, their production and use as pharmaceutical agents
App 20060223833 - Schulze; Volker ;   et al.
2006-10-05
Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060160861 - Bohlmann; Rolf ;   et al.
2006-07-20
Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
App 20060116380 - Bohlmann; Rolf ;   et al.
2006-06-01
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
App 20050054654 - Huth, Andreas ;   et al.
2005-03-10
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
App 20050049281 - Huth, Andreas ;   et al.
2005-03-03
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
App 20050004127 - Strehlke, Peter ;   et al.
2005-01-06
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
Grant 6,790,858 - Strehlke , et al. September 14, 2
2004-09-14
Effector conjugates, methods for their preparation and their pharmaceutical use
App 20040167083 - Bosslet, Klaus ;   et al.
2004-08-26
Method for in vitro diagnosis of endometriosis
Grant 6,780,594 - Hess-Stumpp , et al. August 24, 2
2004-08-24
Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
App 20040152684 - Hegele-Hartung, Christa ;   et al.
2004-08-05
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
App 20040147535 - Huth, Andreas ;   et al.
2004-07-29
Selected anthranilaminde pyridinamides and their use as pharmaceutical agents
App 20040039019 - Huth, Andreas ;   et al.
2004-02-26
Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
App 20030232873 - Koppitz, Marcus Karl ;   et al.
2003-12-18
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
App 20030105328 - Strehlke, Peter ;   et al.
2003-06-05
Method for in vitro diagnosis of endometriosis
App 20030077589 - Hess-Stumpp, Holger ;   et al.
2003-04-24
Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
App 20020143000 - Hegele-Hartung, Christa ;   et al.
2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed